$0.31 -0.01 (-3.12%)
11/6/2009 3:59 PM

Aastrom Biosciences, Inc. (ASTM)

CAPS Rating: No stars

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Current Price $0.31 Mkt Cap $52.18M
Open $0.32 P/E Ratio 0.00
Prev. Close $0.32 Div. (Yield) N/A (N/A)
Daily Range $0.31 - $0.32 Volume 1,030,404
52-Wk Range $0.29 - $0.78 Avg. Daily Vol. 1,812,000

ASTM News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to Watchlist

All Members

22 Outperform
2 Underperform
 

All-Star Members

2 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top ASTM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TheGreatSatan (99.97)
Submitted October 30, 2006

Stemcell friendly election results could buoy the price near term. Beyond that, who knows, it still burns cash like a drunken sailor, with little result (kind of like the 109 congress, since I'm thinking about policits).

2 Comments | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

ASTM VS S&P 500 (SPY)

Fools bullish on ASTM are also bullish on:

Fools bearish on ASTM are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about ASTM.

Recs

0
Member Avatar rtrieone (< 20) Submitted: 4/9/2007 9:08:39 PM : Outperform Start Price: $1.53 ASTM Score: -58.21



They will need time to get the studies done. This stuff works and very exciting to see it all come alive and make a lot of money investing....

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar scott627 (< 20) Submitted: 4/8/2007 7:10:02 PM : Outperform Start Price: $1.61 ASTM Score: -59.05

Using audlt stem cells may take the edge off the whole stem cell debate. They will need to push hard the "adult" angle to come out a winner.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar wynharter (< 20) Submitted: 2/23/2007 1:35:31 PM : Outperform Start Price: $1.50 ASTM Score: -57.62

Their TRC's are non-invasive, personal blood stem cells, being proven a success in clinics and create no side affects. Also non-controversal and morally acceptable.

wyn harter

Report this Post 0 Comments | Reply | Permalink
View All 5 Pitches »

Leaderboard

Find the members with the highest scoring picks in ASTM.

Score Leader

leemanschmidt

leemanschmidt (89.75) Score: +62.82

The Score Leader is the member with the highest score across all their picks in ASTM.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
leemanschmidt 89.75 11/8/2006 Underperform 3W $1.60 -80.62% -17.80% +62.82
steve3rrt < 20 4/9/2007 Underperform 5Y $1.61 -80.75% -21.70% +59.05
johnni5 < 20 2/26/2007 Outperform 3Y $1.51 -79.47% -22.03% -57.44
wynharter < 20 2/23/2007 Outperform 3M $1.50 -79.33% -21.71% -57.62 1 Comment
makalotofmoney < 20 2/15/2007 Outperform 3M $1.52 -79.61% -21.94% -57.66
verncox < 20 2/15/2007 Outperform 1Y $1.52 -79.61% -21.94% -57.66 1 Comment
fps3 < 20 2/15/2007 Outperform 1Y $1.52 -79.61% -21.94% -57.66
nymstocks 45.50 4/10/2007 Outperform 1Y $1.53 -79.74% -21.53% -58.21
rtrieone < 20 4/10/2007 Outperform 3Y $1.53 -79.74% -21.53% -58.21 1 Comment
sunshinlinda < 20 4/3/2007 Outperform NS $1.53 -79.80% -20.78% -59.02
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ASTM.

Featured Broker Partners